Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer

Completed · Not applicable

Conditions studied: Breast Cancer, Breast Cancer Surgery

In brief

The purpose of the study is to determine the optimal, lowest dose of radioactive tracer required for Positron Emission Mammography (PEM), and the accuracy and reliability of PEM in pre-surgical evaluations for patients with newly diagnosed breast cancer anticipating breast-conserving surgery but identified to have a second unsuspected breast cancer by MRI.

Key facts

Study ID

NCT01241721

Run by

Swedish Medical Center

People needed

34

Starts

2010-09-01

Expected to finish

2016-04-01

Last updated by the study team

2016-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be 18 years of age or older
• Newly diagnosed primary breast cancer
• Must have a breast or breast/chest MRI ordered as part of standard of care
• Must meet one or more of the following in Part 1:
• T1 carcinoma of the breast appropriate for breast conserving surgery diagnosis established by core biopsy
• Tis (ductal carcinoma in situ) carcinoma > 2 cm diameter
• Invasive lobular carcinoma of the breast
• Must meet the following in Part 2:
• Known invasive or in situ primary breast cancer identified on pre-surgical breast MRI to have an unsuspected 2nd lesion recommended for biopsy and biopsy has not yet been performed

You may not qualify if…

• Known diabetes mellitus

Where it is running

• Swedish Cancer Institute — Seattle, Washington, United States
• Swedish Cancer Institute Cherry Hill Campus - Comprehensive Breast Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.